Over 1.8 million nonprofits and charities for donors, volunteers and funders

Claim This Nonprofit

More Info

Add to Favorites

Share this Nonprofit

Donate

Nonprofit Overview

Causes: Government & Public Administration, Health, Medical Research, Mental Health, Mental Health Treatment

Mission: Founded in 1986, the Multidisciplinary Association for Psychedelic Studies (MAPS) is a 501(c)(3) non-profit research and educational organization that develops medical, legal, and cultural contexts for people to benefit from the careful uses of psychedelics and marijuana. MAPS furthers its mission by: -Developing psychedelics and marijuana into prescription medicines -Training therapists and working to establish a network of treatment centers -Supporting scientific research into spirituality, creativity, and neuroscience -Educating the public honestly about the risks and benefits of psychedelics and marijuana MAPS envisions a world where psychedelics and marijuana are safely and legally available for beneficial uses, and where research is governed by rigorous scientific evaluation of their risks and benefits.

Results: MAPS has completed two Phase 2 FDA studies using MDMA-assisted psychotherapy to treat PTSD, and is in the process of four other similar studies. MAPS also has a study looking at LSD-assisted psychotherapy for treating end-of-life anxiety, an outcome study of the benefits of ibogaine for opiate dependence, and a protocol to investigate medical marijuana to relieve symptoms of PTSD.

Target demographics: Any person whose life may be aided by the transformative nature of psychedelic psychotherapy

Geographic areas served: Worldwide

Programs: Maps' primary focus is research into mdma-assisted psychotherapy ($1,094,575), especially phase 2 research into mdma-assisted psychotherapy in subjects with chronic, treatment-resistant ptsd. In this fiscal year, maps treated the 18th subject in our charleston, south carolina mdma/ptsd study in 24 veterans, firefighters and police officers. An 8th subject was treated in our study in boulder, colorado for people suffering from ptsd from any source, a fourth subject was treated in our mdma/ptsd study in beer yaakov, israel, and an irb approved the amendments for our mdma/ptsd study in vancouver, canada. A 7th therapist participated in our mdma-assisted psychotherapy therapist training study. In addition to our core clinical research, this fiscal year we began planning a series of studies in collaboration with researchers who work with the u. S. Department of veterans affairs' national center for ptsd. We'll be exploring the use of mdma along with more traditional psychotherapeutic methods for treating ptsd including cognitive-behavioral conjoint therapy, cognitive processing therapy, and prolonged exposure therapy. We also began our study looking at the safety and efficacy of using mdma-assisted therapy for anxiety in adults on the autism spectrum and began preparations for a study of mdma-assisted psychotherapy for end-of-life anxiety. These studies will grow significantly in the coming year. Mdma-study related program expenses include costs of video data storage and streaming systems development, budgeting, contracting, and meetings; the costs of developing the treatment manual; training therapists; blinded therapist adherence training; and costs of reviewing and documenting all published mdma literature. There are also mdma-study related supervision of therapists, presentation of our data at professional conferences, and costs to manage the mdma purchased early in our work and to secure the drug for phase 3 trials expected to begin in 2016. Clinical research general costs cover the development of the infrastructure needed for our mdma clinical trials, including work with communications and fundraising departments, staff professional development and conferences, and video streaming and statistical software. Most of the clinical research expenses are personnel, including personnel at each study site: principal investigators, co-investigators, independent raters, overnight physicians, attendant, and study coordinators, as well as maps' internal staff: the clinical director, research associates, information specials, data coordinators and statistical consultants. Ibogaine research expenses were dedicated to completing our studies in mexico ($3,816), and new zealand ($6,329). Lsd research expenses ($12,185) were primarily used for the march 2014 publication of our lsd end-of-life anxiety article in the journal of nervous and mental disease. Marijuana research ($14,905) covered the costs of developing the protocol for a pilot study in which marijuana will be tested to manage symptoms in 76 veterans with chronic, treatment-resistant ptsd, and our efforts to end the public health service (phs) review and the national institute of drug abuse (nida) monopoly of the sale of marijuana for clinical research.

education expenses include harm reduction, events, publications and communications programs. Our zendo project provides a supportive space for people undergoing difficult psychedelic experiences in order to help turn those experiences into opportunities for learning and personal growth, and to reduce the number of drug-related psychiatric hospitalizations and arrests. Services were provided at five major events in fiscal year 2014: burning man (black rock city, nv), envision (costa rica), afrikaburn (south africa), bicycle day (san francisco, ca), and lightning in a bottle (bradley, ca). In order to share recent findings and to inspire existing and new support, maps produced events on psychedelic and marijuana research in colorado, vancouver and santa cruz; and attended more than 17 events that others produced, providing speakers, exhibits, sales of books and maps bulletins, and free distribution of clinical protocols and articles from peer-reviewed journals. Communications included publishing three maps bulletins, and 12 email newsletters, maintaining maps. Org, mdmaptsd. Org, mapscanada. Org, psychedelicscience. Org, and launching mdma-autism. Org. Maps produced "manifesting minds," with north atlantic books, reprinted albert hofmann's "lsd: my problem child," and began work with stanislav grof on his new book, "the visionary world of h. R. Giger. " in spring 2014, maps offered its first webinar, "psychedelic science," in collaboration with evolver learning labs. Maps saw significant growth in coverage of its work in social, online, and traditional media. Maps. Org had 511,449 unique visits and 1,809,246 page views. Facebook likes more than doubled to 89,282. Twitter followers increased 140%, to 17,099. Youtube subscriptions increased 256% to 5,313. Maps received 344 unique media mentions from online and print publications with significant reach. Media outlets include the los angeles times, the new york times, the san francisco chronicle, reason, scientific american, cnn, usa today, msnbc, time, associated press, fox news, forbes, nbc news, playboy, santa cruz sentinel, tricycle, business insider, npr, vice, and southern california public radio (kpcc).

this year, maps operationalized its long-running fiscal sponsorship program, clarifying and updating contracts, process, and structure. This program supports projects that are in alignment with maps mission and vision by offering donors a way to give to a 501(c) 3 nonprofit organization. Maps monitors the project budget, takes a small fee, and sends the donor a receipt for their contribution.

Community Stories

130 Stories from Volunteers, Donors & Supporters

2

Professional with expertise in this field

Rating: 5

I support MAPS because I'm a 30yr old Iraq and Hurricane Katrina veteran. I've been decorated for my service and recieved an honorable discharge. The Dept. of Veterans Affairs has given me a 100% disability rating for PTSD. I've been in cognitive behavioral therapy for almost six years now. I get so afraid of experiencing the fear of some sessions it discourages me from going or being able to go as deeply into it. It will leave me fatigued for day. I have to take an hour and a half train ride to/from most of my appointments, which for someone who's constantly checking people's hands subconsciously and a problem with turning off that fight or flight feeling.. isn't exactly cohesive for therapy sessions.

I suffer from night terrors, most of the symptoms of PTSD, Major Depressive Disorder, Generalized Panic Disorcder, etc..

I've had experience with MDMA while visiting friends while on leave visiting friends at Brown and I can definitely see how a properly conducted and distributed amount of MDMA would help myself and other veterans like me.

They've tried 6 or 7 different SSRI's and SNRI's and nothing has helped. Wellbutrin, Mirtzapine, trazadone, lorazepam, Ativan, klonopin.. I've had to be perscribed stomach medications and have had to deal with side effects of all these medications. My medicine cabinet looks like a pharmacy. Friendships and relationships in my life have suffered. medical marijuana has finally helped me actually get some sleep sometimes and I have a license for it. I can't admit that to the VA or my doctor though because I would lose my benefits and basically end up homeless.

These studies, all thevwork that MAPS is doing is helping my brothers and sisters-in-arms and will hopefully (if the US Government and pharmaceutical companies allow) will eventually help me. I'm holding on to hope they will succeed but I am broken and online one voice. If anyone can help them or their research please do.

I'd like to help any way I can.

Chris.

4

Professional with expertise in this field

Rating: 5

MAPS is such a solid organization!! I recently participated in a professional training program with them and my mind was opened to new ways of thinking and novel approaches to therapy. Additionally, they took really good care of us from start to finish. They really believe in the potential of psychedelics for healing, without being dogmatic, and they're also just good, down-to-earth people. I envision a future involving a cultural shift toward a more sophistocated and holistic understanding of healing, and I see MAPS at the helm!!

2

Professional with expertise in this field

Rating: 5

MAPS's will be credited with legitimizing psychedelics as therapeutic tools and bringing them to the mainstream. Psychology and psychiatry will forever be thankful.

2 Capucine P.

Professional with expertise in this field

Rating: 5

I have learned about MAPS when working in the field of HIV prevention through harm reduction and I strongly believe in their work, in particular when it comes to the use of MDMA in psychotherapy. Furthermore, war on drugs already proved way more harmful than psychedelics.

1 Michele101

Professional with expertise in this field

Rating: 5

Psychedelics helped me overcome PTSD, alcoholism, and emotional baggage that kept me from being happy, healthy, and successful. Organizations like MAPS not only fund research to make the treatments a medical reality, but reduce stigma associated with their use. As a neuroscientist they have offered to be an umbrella for my research. Bravo MAPS!

1

Professional with expertise in this field

Rating: 5

MAPS has a vision of a world in which psychedelics are used to their full potential for the benefit of mankind instead of being unfairly demonised just because they also have recreational potential.
Without the benefits of psychedelics, I would likely either be dead, in prison, or living a life of crime addicted to methamphetamine, heroin, or some other drug that helps me hide or numb the pain of existence. Psychedelics helped me see the world differently and make something of myself. But my use was illegal, and others could be punished if caught for doing what I did.
If MAPS vision can be realised, no-one need fear this - instead getting the help they need without the danger of a state that will punish them for seeking this help.
There can be no nobler goal than the betterment of humanity in whatever form that takes.

Professional with expertise in this field

Rating: 5

MAPS has taken the lead in guts. It takes guts to dedicate time and energy to their cause, and it is truly a noble one. Psychedelics are to the mind what the telescope is to the cosmos. Their professionalism and dedication bring a level of legitimacy and publicity necessary to encourage honest discussion about these potentially groundbreaking tools. Keep up the good work.

Leana L.

Professional with expertise in this field

Rating: 5

MAPS gives hope to us that we can end the insanity and uninformed hysteria and illegality that surrounds the issue of plant medicines and psychedelics. These medicines have been shown throughout history and throughout the world to be supportive to health and happiness. The current epidemic of PTSD and stress related psychological disorders is threatening the very fabric of our society. This organization is bringing information forward to support responsible research and the healing use of currently illegal substances to the people that will benefit from them. Ending unreasonable and unproductive incarceration of citizens is also important, the war on drugs is keeping us from having access to the very healing medicines that the modern world desperately needs. Thank you for supporting them

Territorio N.

Professional with expertise in this field

Rating: 5

MAPS is frontlining a battle for health and cognitive liberty. What else does matter?

Benjamin5

Professional with expertise in this field

Rating: 5

In determining the usefulness or uselessness of a thing, it is best to allow for certain liberties in keeping with the framers of our Constitution. Fear of the unknown keeps it unknown as Carl Jung has said. One of the tenents of our Constitution is the pursuit of happiness. If a law dis-allows the pursuit of happiness and as studies are now showing, much usefulness to individuals as a medicine, those who seek to ban or stop it are operating from something that in reality does not exist (irrational fear). The rhetoric of status quo and fear must give way to awareness and with the accuracy of science and understanding, it can. With so many lives currently being affected negativley and so much riding on appropriate discourse and knowledge, only insight into and study of a chemical or plant's potential usefulness or uselessness will bring out it's rightful place in our society.